NewsBenzingaOmeros就其用于治疗造血干细胞移植相关血栓性微血管病的Narsoplimab上市许可申请收到EMA CHMP负面意见 Omeros就其用于治疗造血干细胞移植相关血栓性微血管病的Narsoplimab上市许可申请收到EMA CHMP负面意见 Benzinga 2026.10.16 10:22 (GMT+0) Open on Benzinga Other news Susquehanna Maintains Positive on United Airlines Holdings, Lowers Price Target to $130 Susquehanna Maintains Positive on Meta Platforms, Raises Price Target to $850 Alpha Tau Medical Inks MoU With Samsung Medical Center In Seoul Regarding Potential Clinical Study In Pancreatic Cancer Patients Susquehanna Maintains Neutral on IBM, Raises Price Target to $256 Susquehanna Maintains Neutral on Genpact, Raises Price Target to $40 Keybanc Maintains Overweight on Meta Platforms, Raises Price Target to $905
Alpha Tau Medical Inks MoU With Samsung Medical Center In Seoul Regarding Potential Clinical Study In Pancreatic Cancer Patients
